-transparent.png){kind=logo}
Fourteen healthy young women were studied through a control and a treatment menstrual cycle in two series of experiments. In the first series, they were given one of four doses of deglycosylated human chorionic gonadotropin (hCG) as a 24-hour infusion during the mid-luteal phase of the cycle. In these studies, there were no significant alterations of the length of the luteal phase of the treatment cycle, and there was no decrease in serum progesterone (P) during the infusion. In fact, serum P increased during the infusion. In the second series of studies, five subjects were given a 48-hour infusion of normal saline during the control cycle, and a 48-hour infusion of deglycosylated alpha-intact beta-hCG during the treatment cycle, both being administered during the mid-luteal phase. Treatment did not alter luteal phase duration and, again, increased serum P. It is concluded that deglycosylated preparations of hCG are not clinically useful as luteinizing hormone antagonists, probably because of residual agonist activity.
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
March 1990,
Biochimica et biophysica acta,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
November 1992,
Indian journal of experimental biology,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
April 1985,
Biochemistry,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
October 1997,
Thyroid : official journal of the American Thyroid Association,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
October 2005,
Clinical chemistry,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
April 1990,
The Journal of clinical endocrinology and metabolism,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
January 1989,
Hormone research,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
September 2003,
Fertility and sterility,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
January 2018,
Reproductive medicine and biology,
P E Patton, and
F O Calvo, and
V Y Fujimoto, and
E R Bergert, and
R D Kempers, and
R J Ryan
February 1980,
American journal of obstetrics and gynecology,
